Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
Sign Up
Log in
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd banner

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SGX:T14

Watchlist Manager
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd Logo
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SGX:T14
Watchlist
Price: 3.36 USD 2.44%
Market Cap: $4.8B
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

Revenue
+
3Y
-25%
5Y
-21%
10Y
-24%
Operating Income
+
3Y
+22%
5Y
+36%
10Y
+112%
Net Income
+
3Y
+328%
5Y
+444%
10Y
+720%

Earnings Waterfall
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

Income Statement
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

Rotate your device to view
Income Statement
Currency: CNY
Dec-2003 Mar-2004 Jun-2004 Sep-2004 Dec-2004 Mar-2005 Jun-2005 Sep-2005 Dec-2005 Mar-2006 Jun-2006 Sep-2006 Dec-2006 Mar-2007 Jun-2007 Sep-2007 Dec-2007 Mar-2008 Jun-2008 Sep-2008 Dec-2008 Mar-2009 Jun-2009 Sep-2009 Dec-2009 Mar-2010 Jun-2010 Sep-2010 Dec-2010 Mar-2011 Jun-2011 Sep-2011 Dec-2011 Mar-2012 Jun-2012 Sep-2012 Dec-2012 Mar-2013 Jun-2013 Sep-2013 Dec-2013 Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Revenue
Interest Expense
32
0
0
0
47
0
0
0
61
0
0
0
58
0
0
0
84
0
0
0
0
0
0
0
54
0
0
0
43
0
0
0
50
0
0
0
50
0
0
0
52
0
0
0
48
0
0
0
33
0
0
0
17
0
0
3
10
0
0
3
11
8
9
7
5
0
0
0
0
0
0
0
3
0
0
0
10
14
23
34
36
35
37
38
40
36
0
0
Revenue
2 064
N/A
2 086
+1%
2 042
-2%
2 157
+6%
2 116
-2%
2 139
+1%
2 146
+0%
2 174
+1%
2 517
+16%
2 488
-1%
2 583
+4%
2 523
-2%
2 165
-14%
2 252
+4%
2 212
-2%
2 201
-1%
2 258
+3%
2 298
+2%
2 276
-1%
2 355
+3%
2 365
+0%
2 411
+2%
2 503
+4%
2 646
+6%
2 881
+9%
2 944
+2%
3 150
+7%
3 356
+7%
3 474
+3%
3 758
+8%
3 942
+5%
4 136
+5%
4 392
+6%
4 600
+5%
4 884
+6%
5 049
+3%
5 130
+2%
5 345
+4%
5 628
+5%
5 749
+2%
6 010
+5%
6 113
+2%
6 267
+3%
6 621
+6%
7 087
+7%
7 156
+1%
7 114
-1%
7 026
-1%
7 081
+1%
7 104
+0%
6 997
-2%
6 845
-2%
6 243
-9%
6 081
-3%
5 952
-2%
5 747
-3%
5 689
-1%
5 823
+2%
5 814
0%
6 085
+5%
6 359
+5%
6 497
+2%
6 780
+4%
6 847
+1%
6 994
+2%
6 897
-1%
6 751
-2%
6 774
+0%
6 604
-3%
6 775
+3%
6 954
+3%
6 999
+1%
6 908
-1%
6 970
+1%
7 042
+1%
7 118
+1%
8 249
+16%
8 514
+3%
8 563
+1%
8 479
-1%
8 222
-3%
8 153
-1%
8 099
-1%
8 040
-1%
7 307
-9%
6 676
-9%
5 993
-10%
5 366
-10%
Gross Profit
Cost of Revenue
(1 202)
(1 189)
(1 149)
(1 235)
(1 161)
(1 178)
(1 158)
(1 163)
(1 445)
(1 429)
(1 515)
(1 520)
(1 407)
(1 513)
(1 544)
(1 539)
(1 484)
(1 482)
(1 444)
(1 473)
(1 492)
(1 472)
(1 530)
(1 649)
(1 799)
(1 810)
(1 951)
(2 087)
(2 162)
(2 366)
(2 517)
(2 664)
(2 861)
(2 999)
(3 155)
(3 268)
(3 380)
(3 567)
(3 865)
(3 986)
(4 096)
(4 256)
(4 334)
(4 622)
(4 941)
(5 012)
(4 963)
(4 908)
(4 993)
(5 097)
(5 080)
(4 882)
(4 228)
(4 074)
(3 911)
(3 685)
(3 489)
(3 533)
(3 405)
(3 563)
(3 739)
(3 878)
(4 051)
(4 046)
(4 073)
(4 104)
(4 015)
(4 140)
(4 024)
(4 170)
(4 280)
(4 214)
(4 161)
(4 304)
(4 338)
(4 399)
(4 992)
(4 994)
(4 987)
(4 945)
(4 632)
(4 592)
(4 499)
(4 358)
(3 804)
(3 231)
(2 548)
(1 917)
Gross Profit
862
N/A
897
+4%
893
0%
923
+3%
955
+4%
962
+1%
987
+3%
1 011
+2%
1 072
+6%
1 059
-1%
1 068
+1%
1 003
-6%
758
-24%
739
-2%
669
-10%
662
-1%
774
+17%
816
+5%
832
+2%
882
+6%
873
-1%
939
+7%
973
+4%
997
+2%
1 082
+8%
1 134
+5%
1 199
+6%
1 269
+6%
1 312
+3%
1 392
+6%
1 425
+2%
1 472
+3%
1 531
+4%
1 601
+5%
1 729
+8%
1 781
+3%
1 750
-2%
1 778
+2%
1 763
-1%
1 764
+0%
1 915
+9%
1 857
-3%
1 933
+4%
1 999
+3%
2 146
+7%
2 144
0%
2 150
+0%
2 118
-1%
2 088
-1%
2 007
-4%
1 917
-4%
1 963
+2%
2 015
+3%
2 006
0%
2 041
+2%
2 062
+1%
2 201
+7%
2 289
+4%
2 409
+5%
2 522
+5%
2 620
+4%
2 619
0%
2 730
+4%
2 802
+3%
2 921
+4%
2 793
-4%
2 736
-2%
2 634
-4%
2 580
-2%
2 605
+1%
2 674
+3%
2 785
+4%
2 747
-1%
2 666
-3%
2 703
+1%
2 719
+1%
3 257
+20%
3 520
+8%
3 576
+2%
3 535
-1%
3 590
+2%
3 562
-1%
3 599
+1%
3 682
+2%
3 503
-5%
3 445
-2%
3 445
0%
3 449
+0%
Operating Income
Operating Expenses
(789)
(830)
(830)
(848)
(882)
(895)
(919)
(941)
(1 021)
(1 022)
(1 032)
(987)
(1 166)
(1 136)
(1 074)
(1 074)
(960)
(963)
(957)
(965)
(781)
(817)
(848)
(876)
(913)
(950)
(972)
(1 033)
(1 075)
(1 124)
(1 173)
(1 206)
(1 259)
(1 316)
(1 424)
(1 471)
(1 482)
(1 492)
(1 482)
(1 482)
(1 571)
(1 518)
(1 564)
(1 626)
(1 773)
(1 769)
(1 760)
(1 745)
(1 694)
(1 631)
(1 577)
(1 607)
(1 719)
(1 736)
(1 784)
(1 772)
(1 852)
(1 923)
(2 022)
(2 102)
(2 152)
(2 128)
(2 217)
(2 288)
(2 384)
(2 254)
(2 190)
(2 055)
(1 993)
(1 970)
(1 977)
(2 059)
(2 154)
(2 076)
(2 079)
(2 072)
(2 576)
(2 679)
(2 738)
(2 753)
(2 775)
(2 774)
(2 806)
(2 889)
(2 717)
(2 750)
(2 723)
(2 660)
Selling, General & Administrative
(795)
(837)
(836)
(853)
(888)
(902)
(928)
(952)
(1 030)
(1 030)
(1 012)
(965)
(974)
(944)
(907)
(907)
(851)
(849)
(847)
(855)
(785)
(822)
(850)
(878)
(915)
(953)
(975)
(1 037)
(1 069)
(1 122)
(1 171)
(1 202)
(1 236)
(1 301)
(1 409)
(1 457)
(1 458)
(1 478)
(1 468)
(1 468)
(1 313)
(1 530)
(1 577)
(1 638)
(1 511)
(1 760)
(1 750)
(1 733)
(1 510)
(1 601)
(1 544)
(1 572)
(1 633)
(1 682)
(1 707)
(1 702)
(1 741)
(1 873)
(1 946)
(2 030)
(2 002)
(1 989)
(2 099)
(2 155)
(2 193)
(2 126)
(2 055)
(1 934)
(1 830)
(1 846)
(1 845)
(1 914)
(1 948)
(1 931)
(1 929)
(1 912)
(2 373)
(2 483)
(2 546)
(2 555)
(2 561)
(2 537)
(2 575)
(2 655)
(2 520)
(2 474)
(2 449)
(2 390)
Research & Development
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(62)
0
0
0
(71)
0
0
0
(73)
0
0
0
(68)
0
(30)
(44)
(79)
0
(52)
(55)
(96)
(121)
(118)
(126)
(125)
(133)
(126)
(128)
(139)
(158)
(169)
(168)
(150)
(151)
(150)
(159)
(144)
(158)
(150)
(147)
(175)
(185)
(179)
(197)
(155)
(163)
(177)
(168)
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(1)
0
0
0
(187)
0
0
0
(183)
0
0
0
(106)
0
0
0
(53)
0
0
0
(57)
0
0
0
(59)
0
0
0
(74)
0
0
0
(63)
0
0
0
(64)
0
0
0
(61)
0
0
0
(59)
0
0
0
(72)
0
0
0
Other Operating Expenses
6
7
6
5
6
7
9
10
9
9
(20)
(22)
(192)
(192)
(167)
(167)
(109)
(114)
(111)
(110)
4
5
2
1
2
3
3
4
(6)
(2)
(1)
(4)
(23)
(16)
(16)
(14)
(23)
(14)
(14)
(14)
(8)
13
13
13
(8)
(9)
(10)
(12)
(6)
(30)
(33)
(35)
35
(54)
(48)
(27)
25
(50)
(25)
(18)
6
(17)
0
(7)
9
5
(10)
7
40
34
37
23
8
7
0
(1)
3
(37)
(42)
(50)
20
(51)
(51)
(37)
29
(113)
(97)
(102)
Operating Income
73
N/A
67
-8%
63
-6%
75
+19%
73
-2%
67
-9%
68
+2%
70
+2%
51
-27%
37
-27%
37
-2%
16
-57%
(408)
N/A
(397)
+3%
(406)
-2%
(412)
-2%
(186)
+55%
(147)
+21%
(125)
+15%
(83)
+33%
93
N/A
121
+31%
125
+3%
121
-3%
168
+40%
184
+9%
227
+23%
236
+4%
237
+0%
268
+13%
252
-6%
267
+6%
272
+2%
285
+5%
305
+7%
310
+2%
268
-13%
287
+7%
281
-2%
282
+0%
344
+22%
340
-1%
369
+9%
374
+1%
373
0%
375
+1%
390
+4%
373
-4%
393
+5%
376
-4%
340
-10%
356
+5%
296
-17%
270
-9%
257
-5%
290
+13%
348
+20%
366
+5%
387
+5%
420
+9%
468
+11%
491
+5%
513
+4%
514
+0%
537
+4%
538
+0%
545
+1%
578
+6%
588
+2%
634
+8%
696
+10%
726
+4%
593
-18%
590
0%
624
+6%
647
+4%
681
+5%
841
+24%
838
0%
782
-7%
815
+4%
788
-3%
794
+1%
794
0%
786
-1%
695
-12%
722
+4%
789
+9%
Pre-Tax Income
Interest Income Expense
21
24
28
25
17
10
2
0
30
(10)
(4)
13
12
12
43
42
126
98
81
86
(0)
12
10
19
41
55
55
89
69
53
53
18
(0)
18
144
138
232
187
53
49
17
50
59
74
41
57
40
92
30
109
169
138
123
165
193
183
139
208
182
160
168
147
150
189
192
198
203
207
190
190
212
219
262
262
258
313
246
359
398
308
326
295
242
261
186
1 870
3 366
3 378
Non-Reccuring Items
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
44
0
0
0
(0)
0
0
0
76
0
(0)
0
19
20
20
0
37
0
4
5
5
23
21
30
30
0
14
0
8
13
14
15
12
0
0
0
53
1
1
1
(44)
(0)
(0)
0
1 596
0
0
4
Gain/Loss on Disposition of Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
33
0
0
0
48
0
0
0
37
0
0
0
35
0
0
0
(1)
0
0
0
2
0
0
(0)
(1)
(1)
(2)
(2)
(1)
(0)
(1)
(1)
(1)
(2)
(2)
(1)
0
0
0
0
0
0
0
0
(2)
0
0
0
(1)
0
0
0
(1)
0
0
0
(2)
0
0
0
(0)
0
0
0
(1)
0
0
0
(0)
0
0
0
Total Other Income
29
28
30
29
3
17
18
16
23
72
56
38
6
5
4
4
1
35
85
85
23
73
26
64
10
46
45
9
12
45
44
43
12
12
15
17
16
17
16
17
13
14
13
10
18
19
41
42
39
42
29
31
29
28
17
12
7
4
3
4
1
(1)
(2)
(9)
(15)
(14)
(31)
(25)
(16)
(18)
4
7
8
5
0
(4)
1
0
1
2
(1)
(2)
(2)
3
12
10
10
6
Pre-Tax Income
122
N/A
120
-2%
120
+1%
129
+7%
93
-28%
94
+0%
88
-6%
86
-2%
105
+22%
100
-5%
89
-11%
67
-25%
(391)
N/A
(378)
+3%
(358)
+5%
(366)
-2%
(26)
+93%
(15)
+42%
41
N/A
88
+115%
163
+86%
206
+26%
161
-22%
204
+26%
256
+26%
285
+11%
327
+15%
334
+2%
353
+6%
366
+4%
349
-5%
327
-6%
282
-14%
315
+12%
464
+47%
465
+0%
517
+11%
490
-5%
349
-29%
347
-1%
417
+20%
402
-4%
439
+9%
456
+4%
431
-5%
450
+4%
470
+5%
506
+8%
537
+6%
526
-2%
536
+2%
523
-2%
466
-11%
482
+3%
487
+1%
486
0%
531
+9%
579
+9%
576
-1%
589
+2%
641
+9%
659
+3%
681
+3%
723
+6%
743
+3%
722
-3%
730
+1%
761
+4%
768
+1%
820
+7%
926
+13%
968
+5%
873
-10%
857
-2%
883
+3%
957
+8%
980
+2%
1 202
+23%
1 239
+3%
1 094
-12%
1 095
+0%
1 081
-1%
1 034
-4%
1 057
+2%
2 579
+144%
2 575
0%
4 098
+59%
4 176
+2%
Net Income
Tax Provision
(17)
(17)
(18)
(16)
(9)
(9)
(8)
(11)
(12)
(10)
(7)
(3)
(2)
(2)
(3)
(4)
(21)
(21)
(7)
(8)
29
30
31
31
19
12
(13)
(24)
(32)
(40)
(15)
(11)
(15)
(17)
(71)
(72)
(59)
(63)
(34)
(35)
(57)
(54)
(61)
(65)
(51)
(54)
(58)
(63)
(79)
(78)
(71)
(63)
(58)
(56)
(53)
(59)
(58)
(65)
(63)
(71)
(73)
(74)
(75)
(105)
(108)
(104)
(114)
(85)
(88)
(98)
(107)
(104)
(86)
(85)
(91)
(101)
(107)
(133)
(129)
(124)
(127)
(127)
(129)
(138)
(364)
(371)
(611)
(607)
Income from Continuing Operations
105
103
102
113
84
85
80
75
93
90
82
63
(393)
(380)
(361)
(371)
(46)
(36)
33
80
192
235
192
235
275
297
314
310
321
326
334
317
267
299
393
392
458
427
316
312
361
348
377
391
379
396
412
443
458
448
465
461
409
427
434
427
473
514
513
518
568
585
606
618
635
618
615
675
680
722
818
863
787
772
792
856
873
1 069
1 110
969
969
954
905
920
2 215
2 204
3 487
3 568
Income to Minority Interest
(19)
(20)
(15)
(24)
(20)
(21)
(28)
(21)
(12)
(9)
(3)
0
6
(6)
(8)
(12)
(24)
(13)
(20)
(16)
(16)
(16)
(9)
(11)
(17)
(19)
(22)
(33)
(28)
(27)
(33)
(20)
(19)
(21)
(19)
(21)
(17)
(15)
(6)
(5)
(9)
(13)
(16)
(19)
(22)
(21)
(14)
(7)
(6)
4
6
6
15
11
8
6
3
2
(1)
(1)
(6)
(7)
(11)
(12)
(10)
(13)
(13)
(18)
(18)
(17)
(18)
(17)
(18)
(17)
(17)
(19)
(11)
(6)
6
22
18
19
17
13
14
13
12
9
Net Income (Common)
87
N/A
83
-4%
87
+5%
90
+3%
64
-28%
64
+0%
53
-18%
54
+3%
81
+50%
81
+0%
79
-2%
64
-19%
(387)
N/A
(386)
+0%
(369)
+4%
(383)
-4%
(70)
+82%
(50)
+29%
14
N/A
63
+362%
176
+178%
219
+24%
183
-17%
223
+22%
258
+15%
278
+8%
292
+5%
277
-5%
293
+6%
299
+2%
301
+0%
297
-1%
248
-17%
278
+12%
374
+34%
371
-1%
441
+19%
412
-7%
310
-25%
307
-1%
352
+15%
336
-5%
361
+8%
372
+3%
358
-4%
375
+5%
398
+6%
436
+9%
451
+4%
452
+0%
471
+4%
467
-1%
424
-9%
438
+3%
443
+1%
433
-2%
476
+10%
516
+8%
512
-1%
518
+1%
562
+9%
578
+3%
595
+3%
606
+2%
626
+3%
606
-3%
602
-1%
657
+9%
662
+1%
705
+6%
801
+14%
846
+6%
769
-9%
756
-2%
775
+3%
837
+8%
862
+3%
1 063
+23%
1 116
+5%
991
-11%
987
0%
973
-1%
922
-5%
932
+1%
2 229
+139%
2 216
-1%
3 499
+58%
3 578
+2%
EPS (Diluted)
0.12
N/A
0.11
-8%
0.11
N/A
0.11
N/A
0.09
-18%
0.08
-11%
0.07
-12%
0.07
N/A
0.11
+57%
0.11
N/A
0.1
-9%
0.08
-20%
-0.52
N/A
-0.53
-2%
-0.5
+6%
-0.52
-4%
-0.09
+83%
-0.06
+33%
0.02
N/A
0.09
+350%
0.24
+167%
0.29
+21%
0.24
-17%
0.3
+25%
0.35
+17%
0.38
+9%
0.4
+5%
0.38
-5%
0.4
+5%
0.41
+2%
0.41
N/A
0.4
-2%
0.33
-18%
0.37
+12%
0.5
+35%
0.5
N/A
0.6
+20%
0.55
-8%
0.42
-24%
0.41
-2%
0.48
+17%
0.46
-4%
0.49
+7%
0.51
+4%
0.48
-6%
0.51
+6%
0.54
+6%
0.56
+4%
0.59
+5%
0.6
+2%
0.62
+3%
0.61
-2%
0.55
-10%
0.57
+4%
0.58
+2%
0.57
-2%
0.62
+9%
0.68
+10%
0.67
-1%
0.67
N/A
0.73
+9%
0.75
+3%
0.77
+3%
0.79
+3%
0.81
+3%
0.78
-4%
0.78
N/A
0.85
+9%
0.86
+1%
0.93
+8%
1.05
+13%
1.11
+6%
1
-10%
0.98
-2%
1.01
+3%
1.09
+8%
1.11
+2%
1.38
+24%
1.44
+4%
1.28
-11%
1.28
N/A
1.26
-2%
1.19
-6%
1.21
+2%
2.89
+139%
2.88
0%
4.55
+58%
4.65
+2%

See Also

Summary
T14 intrinsic value, competitors valuation, and company profile.
DCF Valuation
T14 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
T14 stock valuation using valuation multiples.
Wall Street Estimates
T14 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
T14 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 327,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett